Key facts: Nordics
| Main buyers | Amgros (Denmark); Sykehusinnkjøp HF (Norway); the Swedish regions, often jointly by healthcare region; Finnish wellbeing services counties and their joint purchasing units |
|---|---|
| Main routes | National or regional hospital tenders by product; joint Nordic tenders for off-patent hospital medicines; Sweden's pharmacy generics follow a monthly lowest-price system |
| Typical term | One to two years, often with extension options |
| Award model | Price-led, with environmental and supply criteria playing a growing role |
How concentrated is Nordic medicine buying?
Very. In Denmark and Norway one national body tenders for the whole hospital sector, so one decision sets the supplier for the country. Losing a round can mean losing a market for one or two years.
Buying is also crossing borders. Denmark, Norway and Iceland run joint Nordic tenders for off-patent hospital medicines, and the round planned for 2028 adds Swedish and Finnish buyers. The Baltic states have also agreed joint purchasing with Denmark.
Are generics tendered in Sweden and Finland?
Hospital medicines are tendered by the Swedish regions and the Finnish counties. Swedish pharmacy generics are not tendered: each month the lowest-priced available product in each exchangeable group becomes the one pharmacies dispense.
Udbud, anbud and upphandling: Nordic tender terms
Amgros runs each Danish udbud and awards a rammeaftale, a framework, usually to one supplier per product. In Norway, Sykehusinnkjøp runs the hospital medicine anbud for the whole country. Swedish regions run each upphandling jointly by healthcare region, and Finnish wellbeing services counties buy through joint purchasing units.
Across all four, the winner is published and the price mostly is not, so the useful history is who won which product, for how long and against whom.
How does RGS help in the Nordics?
We track national, regional and joint Nordic rounds, record the winners per product and keep the calendar of when each product comes back. For Sweden we follow both the regional tenders and the monthly pharmacy system.
What is public in Nordics, and what is not
Tender notices, the estimated quantities in tender documents and the names of the winners are published.
Hospital prices mostly are not. Amgros's negotiated hospital prices are confidential, Norwegian hospital tender prices have been confidential since 2016, and Swedish bidders increasingly ask for their prices to be kept secret. Side agreements on new medicines are confidential everywhere.
Questions about Nordics
Who buys hospital medicines in Denmark?
Amgros, the procurement organisation owned by the Danish regions, tenders medicines for all public hospitals.
Are Nordic tender prices public?
Mostly not. Winners are published, but hospital prices in Denmark and Norway are confidential, and in Sweden they are often kept secret at the bidder's request.
Are generics tendered in Sweden?
Hospital medicines are tendered by the regions. Pharmacy generics are not tendered; a monthly system selects the lowest-priced available product in each group.
Are the prices in an Amgros udbud published?
No. Amgros publishes the winner of each udbud, but the prices are confidential. Norwegian hospital medicine prices have also been confidential since 2016.
Can RGS show confidential contracts and prices in Nordics?
No outside service can, because they are never published. RGS covers what buyers publish. For the confidential part we set up a private pipeline for your company: your own bids, results, buyer correspondence and price lists, loaded next to the public data and visible only to your team.